ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.

UVI Unilens Vision Inc.

0.00
0.00 (0.00%)
Last Updated: -
Delayed by 15 minutes
Share Name Share Symbol Market Type
Unilens Vision Inc. TSXV:UVI TSX Venture Common Stock
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 0 -

Unilens Named Authorized Bausch + Lomb Boston GP Manufacturer

01/11/2012 6:00pm

PR Newswire (US)


Unilens Vision Inc. (TSXV:UVI)
Historical Stock Chart


From Jul 2019 to Jul 2024

Click Here for more Unilens Vision Inc. Charts.
Unilens Named Authorized Bausch + Lomb Boston GP Manufacturer

LARGO, Fla. and WILMINGTON, Mass., Nov. 1, 2012 /PRNewswire/ -- Unilens Vision Inc. (OTC Markets Group OTCQB: UVIC) (TSX Venture Exchange: UVI) and Bausch + Lomb announced today that Unilens has been named an authorized Boston GP Manufacturer. The partnership will provide Unilens' GP independent practitioner accounts with the convenience to choose from a wider variety of GP lens materials that best fit the practitioner's individual patient needs.

"At Unilens, we have a longstanding commitment to supporting the growth and strength of high quality independent optometry with some of the best specialty lens technology, materials and dynamic programs available in the industry today. Our new GP manufacturing partnership with Bausch + Lomb solidifies that commitment by providing our independent practitioners with even more GP lens material options in Unilens/C-VUE lens designs, thereby contributing to more patient satisfaction and practice profitability," stated Michael Pecora, Chief Executive Officer of Unilens Vision Inc.

Unilens' bestselling GP design technology, including the all new C-Ray® Multifocal GP and C-Vue® GP Multifocal, will now be available in a variety of Boston materials including Boston ES®, Boston EO® and Boston XO®

David Bland, Director-Global GP and Custom Soft Lens Business, for Boston Bausch + Lomb added, "We are excited about our partnership with Unilens Vision. Unilens will now be offering their highly successful specialty designs in our leading materials, including Boston XO®, which features a high DK of 100 (ISO/FATT method), and is designed for GP standard and special design applications such as corneas with high oxygen demand and presbyopic designs. Also available through Unilens now will be Boston EO® material and the Boston ES® material, which is a good choice for emerging presbyopes, providing crisp, clear vision at near, intermediate and far distances and has a DK of 18."

All Unilens, C-Ray and C-Vue GP lens options are customizable, are sold exclusively to independent eye care professionals, feature advanced lens design technologies and offer exceptional deliverability.

About Bausch + Lomb
Bausch + Lomb is one of the best-known and most respected healthcare companies in the world. Its core businesses include contact lenses and lens care products, ophthalmic surgical devices and instruments, and ophthalmic pharmaceuticals. Founded in 1853, the company is headquartered in Rochester, N.Y., and employs more than 11,000 people worldwide. Its products are available in more than 100 countries. More information is available at www.bausch.com.

About Unilens Vision Inc. – "The Independent Eye Care Professionals' Contact Lens Company"
Established in 1989, Unilens Vision Inc., through its wholly owned subsidiary Unilens Corp., USA, located in Largo, Florida and its wholly owned subsidiary Unilens Vision Sciences Inc. develops, licenses, manufactures, distributes and markets contact lenses primarily under the C-Vue® brand directly to Independent Eye Care Professionals. Additional information on the Company may be accessed on the Internet at www.unilens.com. The Company's common stock is listed on the OTCQB under the symbol "UVIC" and on the Canadian TSX Venture Exchange under the symbol "UVI".

The information contained in this news release, other than historical information, consists of forward-looking statements that involve risks and uncertainties that could cause actual results to differ materially from those described in such statements. For a discussion of certain factors that could cause actual results to differ materially from those described in the forward-looking statements, please refer to the Company's most recent filings with the SEC and the TSX Venture Exchange. The TSX Venture Exchange has not reviewed and does not accept responsibility for the adequacy or accuracy of this release.

PRESS CONTACTS:


Kelly McKnight

David Bland

Vice President

Director, GP & Custom Soft Lens Business

Unilens Corp, USA 

Bausch + Lomb

10431 72nd Street North 

100 Research Drive     

Largo, FL 33777 

Wilmington, MA 01887

800-446-2020 (ext. 338 and 405) 

(800) 225-1241

Kelly.mcknight@unilens.com

David.Bland@bausch.com

SOURCE Unilens Vision Inc.

Copyright 2012 PR Newswire

1 Year Unilens Vision Inc. Chart

1 Year Unilens Vision Inc. Chart

1 Month Unilens Vision Inc. Chart

1 Month Unilens Vision Inc. Chart

Your Recent History

Delayed Upgrade Clock